Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382157.RASLqWXtHLlDVK9-ZK8qFGnkkv7_Sg-uLGBxkXhwgrmuU130_provenance.
• NP797354.RAq6ZYl969-CqmRdTG1VFPPELc4l5GtwpoIVkYyAk5uCU130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797354.RAq6ZYl969-CqmRdTG1VFPPELc4l5GtwpoIVkYyAk5uCU130_provenance.
• NP342922.RAKgQlIO0d7dxOHK556c7DAnxDqFC7o8eOgrGe3Uz68xo130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342922.RAKgQlIO0d7dxOHK556c7DAnxDqFC7o8eOgrGe3Uz68xo130_provenance.
• NP802304.RATKUR-viM3cegoda3yPjYVY2f28l0UdckicLKVqTBk04130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802304.RATKUR-viM3cegoda3yPjYVY2f28l0UdckicLKVqTBk04130_provenance.
• NP802412.RAUPvMMhiOnGgo8PEEEDlfnhzKlNOsY00aieJpFhmXVMM130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802412.RAUPvMMhiOnGgo8PEEEDlfnhzKlNOsY00aieJpFhmXVMM130_provenance.
• assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP947577.RAAygqf1uG9t5yvHauLZ2yoByZxCFgXIrTDGVgoF6J_OE130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947577.RAAygqf1uG9t5yvHauLZ2yoByZxCFgXIrTDGVgoF6J_OE130_provenance.
• NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860288.RAOQrAAuHeipSCUgZBnXq3Xo13_gToOplx2Ch41xd8Nfs130_provenance.
• NP458351.RAUVITRs0YBENTYpCO8SxWlO7Bs4v8anqSHelXKRSUDr8130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458351.RAUVITRs0YBENTYpCO8SxWlO7Bs4v8anqSHelXKRSUDr8130_provenance.
• assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP940987.RABcT95JmRdnNOT-vdfk5VqgVwdDEcRz07NZOku9Cuwjs130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940987.RABcT95JmRdnNOT-vdfk5VqgVwdDEcRz07NZOku9Cuwjs130_provenance.
• NP802469.RAj4sQkDUTMtmvDqZd9-6sNhDbiE4KypQmrmMYhp3sJCw130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802469.RAj4sQkDUTMtmvDqZd9-6sNhDbiE4KypQmrmMYhp3sJCw130_provenance.
• NP947376.RAlBrgpinJqDbNGpKJc2OcwIVj6WkUI8EALESFqUmBVgc130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947376.RAlBrgpinJqDbNGpKJc2OcwIVj6WkUI8EALESFqUmBVgc130_provenance.
• NP458347.RAkKJSNonfNBlZXn3T9jZHBkJ8N6EY-_lCJy9HR0jH1IE130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458347.RAkKJSNonfNBlZXn3T9jZHBkJ8N6EY-_lCJy9HR0jH1IE130_provenance.
• NP458349.RAvdYBxp5A1694Oc5V6bgawQ0J_MHvEyswEdJHgcF1Das130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458349.RAvdYBxp5A1694Oc5V6bgawQ0J_MHvEyswEdJHgcF1Das130_provenance.
• NP941062.RAvXnpY1yoBjq68HI56oTGizhpAbgKoPUVHfPJAEcCke8130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941062.RAvXnpY1yoBjq68HI56oTGizhpAbgKoPUVHfPJAEcCke8130_provenance.
• NP569309.RAzvwQsKM59XZtzpvl1Ng40p9zeBJO-LHlW6v4Oahs8eI130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569309.RAzvwQsKM59XZtzpvl1Ng40p9zeBJO-LHlW6v4Oahs8eI130_provenance.
• NP947509.RAKgJc8cM0YlvcW-z6OgFeD5SXPUjsWob5Ja0GMzUtrYQ130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947509.RAKgJc8cM0YlvcW-z6OgFeD5SXPUjsWob5Ja0GMzUtrYQ130_provenance.
• NP458348.RAKdVL6p9UImVTXL69jlhJIUf4F8QzYo_5fgh3UJuuEc4130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458348.RAKdVL6p9UImVTXL69jlhJIUf4F8QzYo_5fgh3UJuuEc4130_provenance.
• NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_provenance.
• NP940827.RA71EEOzIHE4PsvzT_6tknRRE0J1V3zCIdXmlcIuq961o130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940827.RA71EEOzIHE4PsvzT_6tknRRE0J1V3zCIdXmlcIuq961o130_provenance.